Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Fuji
McKinsey
Argus Health
US Department of Justice
Moodys
Julphar
McKesson

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203413

« Back to Dashboard

NDA 203413 describes CYCLAFEM 0.5/35, which is a drug marketed by Vintage Pharms and is included in one NDA. Additional details are available on the CYCLAFEM 0.5/35 profile page.

The generic ingredient in CYCLAFEM 0.5/35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 203413
Tradename:CYCLAFEM 0.5/35
Applicant:Vintage Pharms
Ingredient:ethinyl estradiol; norethindrone
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;0.5MG
Approval Date:Dec 16, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Cerilliant
McKesson
Farmers Insurance
Citi
Baxter
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.